01345nas a2200313 4500000000100000008004100001260001700042653001200059653001500071653004400086653003000130653002000160653001100180653002300191653001200214653000900226653001700235653001500252653001600267100001400283700001200297700002000309700001500329245012200344300001000466490000700476520053400483022001401017 2005 d c2005 May-Jun10aAbscess10aAdolescent10aAnti-Inflammatory Agents, Non-Steroidal10aDrug Therapy, Combination10aGlucocorticoids10aHumans10aLeprostatic Agents10aleprosy10aMale10aPrednisolone10aRecurrence10aUlnar nerve1 aAgrawal A1 aDalal M1 aMakkannavar J H1 aShetty J P00aUlnar nerve abscess and relapse in a patient with indeterminate leprosy 1 year after completion of multidrug therapy. a162-40 v413 a

The introduction of multidrug therapy has efficiently controlled leprosy in developing countries. However, Mycobacterium laprae may survive and cause relapse despite adequate treatment with antileprosy drugs. Relapse may be characterized by a combination of new signs or symptoms and presence of acid-fast bacilli on skin or nerve biopsy samples. We report a case of a child in whom ulnar abscess developed 12 months after successful completion of multidrug therapy with clinical and histopathological evidence of relapse.

 a1016-2291